Rossari Biotech’s Subsidiary Unitop Chemicals Commissions Ethoxylation Capacity Expansion

Rossari Biotech’s Subsidiary Unitop Chemicals Commissions Ethoxylation Capacity Expansion​

Rossari Biotech Ltd announced that its subsidiary, Unitop Chemicals Private Limited, has successfully commissioned an additional 15,000 MTPA of ethoxylation capacity at its Dahej facility, effective March 31, 2026. This follows previous updates provided on October 19, 2023, October 17, 2024, and September 26, 2025, regarding the capacity expansion project.

The total planned expansion at Unitop’s Dahej facility was 30,000 MTPA. With the recent commissioning, Unitop’s total installed ethoxylation capacity now stands at 66,000 MTPA.

Source:​

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.